Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1991 2
1992 4
1993 3
1994 2
1995 2
1997 7
1998 4
1999 3
2000 1
2001 2
2002 2
2003 2
2004 3
2005 2
2006 1
2007 2
2008 4
2009 10
2010 9
2011 3
2012 4
2013 8
2014 8
2015 17
2016 7
2017 16
2018 17
2019 32
2020 29
2021 30
2022 15
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
IgG4-related hypophysitis.
Amirbaigloo A, Esfahanian F, Mouodi M, Rakhshani N, Zeinalizadeh M. Amirbaigloo A, et al. Endocrine. 2021 Aug;73(2):270-291. doi: 10.1007/s12020-021-02714-0. Epub 2021 Apr 10. Endocrine. 2021. PMID: 33837927 Review.
In this paper, we present an Iranian patient with biopsy-proven IgG4-related hypophysitis and then review the clinical characteristics, laboratory, imaging, pathologic findings and therapeutic management as well as prognosis of 115 published cases of hypophysitis secondary …
In this paper, we present an Iranian patient with biopsy-proven IgG4-related hypophysitis and then review the clinical characteristics, labo …
Hypophysitis.
Fukuoka H. Fukuoka H. Endocrinol Metab Clin North Am. 2015 Mar;44(1):143-9. doi: 10.1016/j.ecl.2014.10.011. Epub 2014 Nov 4. Endocrinol Metab Clin North Am. 2015. PMID: 25732650 Review.
In addition, discusses the pathophysiology, clinical features, management, and prognosis associated with this disease are discussed....
In addition, discusses the pathophysiology, clinical features, management, and prognosis associated with this disease are discussed.. …
Pituitary Autoimmunity.
Guaraldi F, Giordano R, Grottoli S, Ghizzoni L, Arvat E, Ghigo E. Guaraldi F, et al. Front Horm Res. 2017;48:48-68. doi: 10.1159/000452905. Epub 2017 Feb 28. Front Horm Res. 2017. PMID: 28245451 Review.
In this context, the demonstration of APA is not sufficient, because of the lack of specificity, and associated methodological and theoretical issues (i.e. disease marker vs. pathogen; antigen target(s); and diagnostic/prognostic significance). This chapter aims at providi …
In this context, the demonstration of APA is not sufficient, because of the lack of specificity, and associated methodological and theoretic …
Other Pituitary Conditions and Pregnancy.
Chanson P. Chanson P. Endocrinol Metab Clin North Am. 2019 Sep;48(3):583-603. doi: 10.1016/j.ecl.2019.05.005. Epub 2019 Jun 18. Endocrinol Metab Clin North Am. 2019. PMID: 31345525 Review.
Diagnosis of lymphocytic hypophysitis occurring in the peripartum period is based on clinical and neuroradiological data and does not require a biopsy. Its course is generally spontaneously favorable in terms of mass effect but may require the administration of corticoster …
Diagnosis of lymphocytic hypophysitis occurring in the peripartum period is based on clinical and neuroradiological data and does not requir …
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, Zhong J, Yushak ML, Harvey RD, Paulos CM, Lawson DH, Khan MK, Kudchadkar RR, Buchwald ZS. Qian DC, et al. Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12. Lancet Oncol. 2021. PMID: 34780711 Clinical Trial.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Tawbi HA, Forsyth PA, Hodi FS, Algazi AP, Hamid O, Lao CD, Moschos SJ, Atkins MB, Lewis K, Postow MA, Thomas RP, Glaspy J, Jang S, Khushalani NI, Pavlick AC, Ernstoff MS, Reardon DA, Kudchadkar R, Tarhini A, Chung C, Ritchings C, Durani P, Askelson M, Puzanov I, Margolin KA. Tawbi HA, et al. Lancet Oncol. 2021 Dec;22(12):1692-1704. doi: 10.1016/S1470-2045(21)00545-3. Epub 2021 Nov 10. Lancet Oncol. 2021. PMID: 34774225 Free PMC article. Clinical Trial.
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
Stroud CR, Hegde A, Cherry C, Naqash AR, Sharma N, Addepalli S, Cherukuri S, Parent T, Hardin J, Walker P. Stroud CR, et al. J Oncol Pharm Pract. 2019 Apr;25(3):551-557. doi: 10.1177/1078155217745144. Epub 2017 Dec 5. J Oncol Pharm Pract. 2019. PMID: 29207939
As a result, we adopted the use of tocilizumab for the management of steroid refractory irAEs. METHODS: The character and clinical course of irAEs were abstracted from the medical record and analyzed. ...
As a result, we adopted the use of tocilizumab for the management of steroid refractory irAEs. METHODS: The character and clinical course …
Imaging findings in hypophysitis: a review.
Caranci F, Leone G, Ponsiglione A, Muto M, Tortora F, Muto M, Cirillo S, Brunese L, Cerase A. Caranci F, et al. Radiol Med. 2020 Mar;125(3):319-328. doi: 10.1007/s11547-019-01120-x. Epub 2019 Dec 20. Radiol Med. 2020. PMID: 31863360 Review.
The greatest challenge in the management of HP is establishing a diagnosis through clinical criteria and non-invasive methods and predicting the patients' clinical outcome. The aim of this review is to describe the neuroradiological findings of this rare disease, providing …
The greatest challenge in the management of HP is establishing a diagnosis through clinical criteria and non-invasive methods and predict …
243 results